Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether taking losartan helps people with
hypertrophic nonobstructive cardiomyopathy feel better by decreasing the amount of heart
muscle thickening and/or the amount of heart muscle scarring.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Angiotensin II Angiotensin Receptor Antagonists Losartan